Dr. Christensen is an Instructor in Medicine at Brigham and Women’s Hospital and Harvard Medical School whose research focuses on the medical, behavioral, and economic impact of integrating genomic tools into clinical and research settings. He has been an investigator on numerous high-profile NIH-funded studies of genomic information disclosure, including the BabySeq and MedSeq Projects, two randomized trials of integrating genomic sequencing in the care of adults and newborn care. His published work has demonstrated the safety and personal utility of disclosing genetic risk information to healthy patients, and provided some of the earliest evidence about the unanticipated benefits of disclosing secondary genomic findings. His work on the MedSeq Project also provided some of the earliest insight about the cost impact of integrating whole genome sequencing into the everyday care of cardiology and primary care patients.